Cypress Acquires Personalized Medicine Technology from Cellatope

Cypress will pay up to $5 million for the technology, which it plans to use for diagnosis and therapeutic monitoring of lupus patients.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.